degradation

Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia

Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm…

1 week ago

Seraphim Awarded ‘Top Performer’ in Kiwa PVEL’s 2025 PV Module Reliability Scorecard for Sixth Time

SHANGHAI, June 11, 2025 /PRNewswire/ -- Recently, Kiwa PV Evolution Labs (Kiwa PVEL), a globally recognized independent testing laboratory, released its 2025…

6 months ago